DeepMed Research

UNIVERSITY COLLEGE LONDON

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1826-02-11

Employees: 10K

Market Cap: -

Website: http://www.ucl.ac.uk

Clinical Trials

Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis

Phase 2

Completed

Conditions: Tuberculosis, Pulmonary

Interventions: Drug: Rifampicin
Drug: Isoniazid
Drug: Pyrazinamide
Drug: Ethambutol
Drug: Linezolid
Drug: Clofazimine
Drug: Rifapentine
Drug: Levofloxacin
Drug: Bedaquiline

First Posted Date: 2018-03-22

Last Posted Date: 2023-08-14

Lead Sponsor: University College, London

Target Recruit Count: 675

Registration Number: NCT03474198

Locations: 🇮🇩
Saiful Anwar Hospital, Malang, Indonesia
🇺🇬
Joint Clinical Research Centre, Mbarara, Uganda
🇺🇬
Infectious Diseases Institute, Kampala, Uganda

and more 14 locations

Measuring Physical Activity Levels in Critical Care

Completed

Conditions: Critical Care

First Posted Date: 2018-03-06

Last Posted Date: 2020-03-26

Lead Sponsor: University College, London

Target Recruit Count: 12

Registration Number: NCT03454880

Locations: 🇬🇧
Univeristy Hospital Wales, Cardiff, United Kingdom

Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal Cancer

Phase 2

Active, not recruiting

Conditions: Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Cancer

Interventions: Drug: Pembrolizumab

First Posted Date: 2018-02-13

Last Posted Date: 2023-01-30

Lead Sponsor: University College, London

Target Recruit Count: 28

Registration Number: NCT03430700

Locations: 🇬🇧
UCLH, London, United Kingdom
🇬🇧
Churchill Hospital, Oxford, United Kingdom
🇬🇧
Barts, London, United Kingdom

and more 1 locations

A Study of Pembrolizumab in Patients With Advanced Gynaecological Clear Cell Cancer

Phase 2

Active, not recruiting

Conditions: Clear Cell Tumor
Gynecologic Cancer
Advanced Cancer

Interventions: Drug: Pembrolizumab

First Posted Date: 2018-02-07

Last Posted Date: 2024-04-12

Lead Sponsor: University College, London

Target Recruit Count: 48

Registration Number: NCT03425565

Locations: 🇬🇧
University College Hospital, London, United Kingdom
🇬🇧
Western General Hospital, Edinburgh, United Kingdom
🇬🇧
The Christie Hospital, Manchester, United Kingdom

and more 2 locations

Serum Uric Acid Levels and Onset of Cardiovascular Diseases: a CALIBER Study

Conditions: Intracerebral Hemorrhage
Peripheral Arterial Disease
Myocardial Infarction
Cardiac Arrest
Subarachnoid Hemorrhage
Abdominal Aortic Aneurysm
Atrial Fibrillation
Stable Angina
Unheralded Coronary Heart Disease Death
Heart Failure

First Posted Date: 2018-02-07

Last Posted Date: 2018-02-07

Lead Sponsor: University College, London

Target Recruit Count: 180000

Registration Number: NCT03425305

A Study Into the Underlying Biochemical Pathways Involved in Parkinson's Disease, Such as Mitochondrial (Cellular "Powerhouse") Dysfunction

Completed

Conditions: Parkinsonism
Parkinson Disease

First Posted Date: 2018-02-05

Last Posted Date: 2023-05-23

Lead Sponsor: University College, London

Target Recruit Count: 160

Registration Number: NCT03421899

Locations: 🇬🇧
UCL Institute of Neurology, Department of Clinical Neurosciences, Upper 3rd Floor, Royal Free Hospital, Rowland Hill Street, London, United Kingdom

Short Pulse Width DBS in Parkinson's Disease

Phase 2

Completed

Conditions: Parkinson's Disease

Interventions: Device: Deep brain stimulation

First Posted Date: 2018-01-31

Last Posted Date: 2019-04-17

Lead Sponsor: University College, London

Target Recruit Count: 16

Registration Number: NCT03417271

Locations: 🇬🇧
UCL Institute of Neurology, London, United Kingdom

Regional Bone Turnover Using 18F-fluoride-PET/CT in HIV-1-infected Men: PETRAM Study

Conditions: HIV Infections

First Posted Date: 2018-01-19

Last Posted Date: 2018-07-30

Lead Sponsor: University College, London

Target Recruit Count: 30

Registration Number: NCT03405012

Locations: 🇬🇧
Mortimer Market Centre, London, United Kingdom

Radiofrequency Endoscopic Ablation With Ultrasound Guidance: a Non-surgical Treatment for Aldosterone-producing Adenomas

Not Applicable

Completed

Conditions: Primary Hyperaldosteronism Due to Adrenal Adenoma
Primary Hyperaldosteronism

Interventions: Procedure: Endoscopic ultrasound guided radiofrequency ablation
Device: ultrasound

First Posted Date: 2018-01-19

Last Posted Date: 2023-05-12

Lead Sponsor: University College, London

Target Recruit Count: 28

Registration Number: NCT03405025

Locations: 🇬🇧
Queen Mary University of London, London, United Kingdom
🇬🇧
University College London, London, United Kingdom
🇬🇧
University of Cambridge and Cambridge NIHR Biomedical Research Centre, Cambridge, United Kingdom

Multiple Sclerosis-Simvastatin Trial 2

Phase 3

Active, not recruiting

Conditions: Secondary Progressive Multiple Sclerosis (SPMS)

Interventions: Drug: Placebo
Drug: Simvastatin

First Posted Date: 2018-01-02

Last Posted Date: 2022-07-07

Lead Sponsor: University College, London

Target Recruit Count: 964

Registration Number: NCT03387670

Locations: 🇬🇧
Southmead Hospital, Bristol, United Kingdom
🇬🇧
St Luke s Hospital, Bradford, United Kingdom
🇬🇧
Kent and Canterbury Hospital, Canterbury, United Kingdom

and more 28 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy